{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T00:49:58Z","timestamp":1787791798483,"version":"build-2784847793"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cytokine"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1016\/j.cyto.2024.156708","type":"journal-article","created":{"date-parts":[[2024,7,24]],"date-time":"2024-07-24T01:37:17Z","timestamp":1721785037000},"page":"156708","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["T cells exhaustion, inflammatory and cellular activity markers in PBMCs predict treatment outcome in pulmonary tuberculosis patients"],"prefix":"10.1016","volume":"182","author":[{"given":"Jacob","family":"Nii Otinkorang Ankrah","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fredrick","family":"Gyilbagr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ezekiel Kofi","family":"Vicar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuel","family":"Antwi Boasiako Frimpong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rukaya Baanah","family":"Alhassan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ibrahim","family":"Sibdow Baako","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alahaman Nana","family":"Boakye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel Addo","family":"Akwetey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akosua Bonsu","family":"Karikari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felix Kodzo Besah","family":"Sorvor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2938-1332","authenticated-orcid":false,"given":"Williams","family":"Walana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cyto.2024.156708_b0005","doi-asserted-by":"crossref","unstructured":"M. De Martino, L. Lodi, L. Galli, E. Chiappini, Immune Response to Mycobacterium tuberculosis\u00a0: A Narrative Review, vol. 7, no. August, pp. 1\u20138, 2019, doi: 10.3389\/fped.2019.00350.","DOI":"10.3389\/fped.2019.00350"},{"key":"10.1016\/j.cyto.2024.156708_b0010","unstructured":"WHO, Tuberculosis, 2023. https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/tuberculosis (accessed Jun. 22, 2024)."},{"key":"10.1016\/j.cyto.2024.156708_b0015","unstructured":"WHO, Country Disease Outlook: Malawi, no. August, p. 3, 2023, [Online]. Available: https:\/\/www.afro.who.int\/sites\/default\/files\/2023-08\/Malawi.pdf."},{"key":"10.1016\/j.cyto.2024.156708_b0020","doi-asserted-by":"crossref","unstructured":"C. Fenwick et al., T-cell exhaustion in HIV infection, no. January 2020, 2019, doi: 10.1111\/imr.12823.","DOI":"10.1111\/imr.12823"},{"issue":"7","key":"10.1016\/j.cyto.2024.156708_b0025","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/ijms18071517","article-title":"Programmed cell death 1 (PD-1) and cytotoxic T lymphocyte-associated antigen 4 (CTLA-4) in viral hepatitis","volume":"18","author":"Cho","year":"2017","journal-title":"Int. J. Mol. Sci."},{"issue":"8","key":"10.1016\/j.cyto.2024.156708_b0030","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11274-023-03636-x","article-title":"Clinical manifestations and immune response to tuberculosis","volume":"39","author":"Carabal\u00ed-Isajar","year":"2023","journal-title":"World J. Microbiol. Biotechnol."},{"key":"10.1016\/j.cyto.2024.156708_b0035","doi-asserted-by":"crossref","unstructured":"D. Tiwari, A.R. Martineau, Inflammation-mediated tissue damage in pulmonary tuberculosis and host-directed therapeutic strategies, Semin. Immunol., vol. 65, no. November 2022, p. 101672, 2023, doi: 10.1016\/j.smim.2022.101672.","DOI":"10.1016\/j.smim.2022.101672"},{"issue":"5","key":"10.1016\/j.cyto.2024.156708_b0040","article-title":"Cytokines and chemokines in mycobacterium tuberculosis infection","volume":"4","author":"Domingo-Gonzalez","year":"2016","journal-title":"Am. Soc. Microbiol. Spectrum."},{"issue":"JAN","key":"10.1016\/j.cyto.2024.156708_b0045","first-page":"1","article-title":"Mycobacterium tuberculosis infection and inflammation: What is beneficial for the host and for the bacterium?","volume":"2","author":"Sasindran","year":"2011","journal-title":"Front. Microbiol."},{"issue":"6","key":"10.1016\/j.cyto.2024.156708_b0050","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1089\/jir.2008.0027","article-title":"Monocyte chemoattractant protein-1 (MCP-1): An overview","volume":"29","author":"Deshmane","year":"2009","journal-title":"J. Interf. Cytokine Res."},{"issue":"February","key":"10.1016\/j.cyto.2024.156708_b0055","first-page":"1","article-title":"The macrophage response to mycobacterium tuberculosis and opportunities for autophagy inducing nanomedicines for tuberculosis therapy","volume":"10","author":"Maphasa","year":"2021","journal-title":"Front. Cell. Infect. Microbiol."},{"issue":"December","key":"10.1016\/j.cyto.2024.156708_b0060","first-page":"1","article-title":"Reinventing the human tuberculosis (TB) granuloma: Learning from the cancer field","volume":"13","author":"Ashenafi","year":"2022","journal-title":"Front. Immunol."},{"issue":"March","key":"10.1016\/j.cyto.2024.156708_b0065","first-page":"1","article-title":"The role of PD-1 in acute and chronic infection","volume":"11","author":"Jubel","year":"2020","journal-title":"Front. Immunol."},{"issue":"2","key":"10.1016\/j.cyto.2024.156708_b0070","doi-asserted-by":"crossref","first-page":"pp","DOI":"10.1038\/s41419-018-1237-y","article-title":"Mycobacterium tuberculosis antigens repress Th1 immune response suppression and promotes lung cancer metastasis through PD-1\/PDl-1 signaling pathway","volume":"10","author":"Cao","year":"2019","journal-title":"Cell Death Dis."},{"issue":"1","key":"10.1016\/j.cyto.2024.156708_b0075","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1097\/SHK.0b013e3182168cce","article-title":"Dose-dependent effect of anti-CTLA-4 on survival in sepsis","volume":"36","author":"Inoue","year":"2011","journal-title":"Shock"},{"key":"10.1016\/j.cyto.2024.156708_b0080","doi-asserted-by":"crossref","unstructured":"E.I. Buchbinder, A. Desai, CTLA-4 and PD-1 Pathways, vol. 39, no. 1, pp. 98\u2013106, 2016, doi: 10.1097\/COC.0000000000000239.","DOI":"10.1097\/COC.0000000000000239"},{"key":"10.1016\/j.cyto.2024.156708_b0085","doi-asserted-by":"crossref","unstructured":"L. Sun et al., Advances in Understanding the Roles of CD244 (SLAMF4) in Immune Regulation and Associated Diseases, vol. 12, no. March, pp. 1\u201310, 2021, doi: 10.3389\/fimmu.2021.648182.","DOI":"10.3389\/fimmu.2021.648182"},{"key":"10.1016\/j.cyto.2024.156708_b0090","doi-asserted-by":"crossref","unstructured":"Y. Wang et al., Long noncoding RNA derived from CD244 signaling epigenetically controls CD8 + T-cell immune responses in tuberculosis infection, 2015, doi: 10.1073\/pnas.1501662112.","DOI":"10.1073\/pnas.1501662112"},{"key":"10.1016\/j.cyto.2024.156708_b0095","doi-asserted-by":"crossref","unstructured":"S. Gertel, 3 + T cells are decreased in active psoriatic arthritis patients and their restoration in vitro is mediated by TNF inhibitors, no. April, pp. 173\u2013183, 2021, doi: 10.1111\/cei.13646.","DOI":"10.1111\/cei.13646"},{"issue":"3","key":"10.1016\/j.cyto.2024.156708_b0100","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1016\/j.ajpath.2014.11.003","article-title":"LAG3 Expression in Active Mycobacterium tuberculosis Infections","volume":"185","author":"Phillips","year":"2015","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.cyto.2024.156708_b0105","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/1297131","article-title":"Expression of USP18 and IL2RA is increased in individuals receiving latent tuberculosis treatment with isoniazid","volume":"2019","author":"De Oyarzabal","year":"2019","journal-title":"J. Immunol. Res."},{"issue":"1","key":"10.1016\/j.cyto.2024.156708_b0110","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1093\/imammb\/dqw021","article-title":"The Effects of Interleukin-2 on immune response regulation","volume":"35","author":"Perry","year":"2018","journal-title":"Mathematical Med. Biol.: J. IMA"},{"key":"10.1016\/j.cyto.2024.156708_b0115","doi-asserted-by":"crossref","unstructured":"Q. Sa, J. Woodward, Y. Suzuki, E. Alerts, This information is current as of December 2, 2013, 2013, doi: 10.4049\/jimmunol.1202256.","DOI":"10.4049\/jimmunol.1202256"},{"issue":"10","key":"10.1016\/j.cyto.2024.156708_b0120","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1002343","article-title":"Genetic diversity in cytokines associated with immune variation and resistance to multiple pathogens in a natural rodent population","volume":"7","author":"Turner","year":"2011","journal-title":"PLoS Genetics"},{"key":"10.1016\/j.cyto.2024.156708_b0125","doi-asserted-by":"crossref","unstructured":"L.L. Tirore, T. Ersido, T.B. Handiso, A.S. Areba, Non-adherence to anti-tuberculosis treatment and associated factors among TB patients in public health facilities of Hossana town, Southern, no. March, pp. 1\u20139, 2024, doi: 10.3389\/fmed.2024.1360351.","DOI":"10.3389\/fmed.2024.1360351"},{"issue":"1","key":"10.1016\/j.cyto.2024.156708_b0130","first-page":"63","article-title":"Therapeutic potential of interferon-gamma in tuberculosis","volume":"10","author":"Berns","year":"2022","journal-title":"ADMET and DMPK"},{"issue":"January","key":"10.1016\/j.cyto.2024.156708_b0135","doi-asserted-by":"crossref","first-page":"100300","DOI":"10.1016\/j.jctube.2022.100300","article-title":"Journal of clinical tuberculosis and other mycobacterial diseases tuberculosis pathophysiology and anti-VEGF intervention","volume":"27","author":"Maison","year":"2022","journal-title":"J. Clin. Tuberc. Other Mycobact. Dis."},{"key":"10.1016\/j.cyto.2024.156708_b0140","doi-asserted-by":"crossref","unstructured":"G. Shanmuganathan, et al., Role of Interferons in Mycobacterium tuberculosis Infection, pp. 788\u2013796, 2022.","DOI":"10.3390\/clinpract12050082"},{"issue":"1","key":"10.1016\/j.cyto.2024.156708_b0145","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1365-2249.2010.04146.x","article-title":"How tumour necrosis factor blockers interfere with tuberculosis immunity","volume":"161","author":"Harris","year":"2010","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.cyto.2024.156708_b0150","doi-asserted-by":"crossref","unstructured":"D. Lo, Y. Mantel, D. Lo, Granzyme B attenuates bacterial virulence by targeting secreted factors killer lymphocyte Secre on systems proteins Granzyme B attenuates bacterial virulence by targeting secreted factors, 2020, doi: 10.1016\/j.isci.2020.100932.","DOI":"10.1016\/j.isci.2020.100932"},{"issue":"April","key":"10.1016\/j.cyto.2024.156708_b0155","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.molimm.2023.08.014","article-title":"Mycobacterium tuberculosis infection depressed cytotoxic T cells activity owing to decreasing NKG2C and increasing NKG2A expression","volume":"162","author":"Shen","year":"2023","journal-title":"Mol. Immunol."},{"issue":"August 2018","key":"10.1016\/j.cyto.2024.156708_b0160","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.tube.2018.10.011","article-title":"B lymphocytes in anti-mycobacterial immune responses: Pathogenesis or protection?","volume":"114","author":"Dyatlov","year":"2019","journal-title":"Tuberculosis"},{"key":"10.1016\/j.cyto.2024.156708_b0165","doi-asserted-by":"crossref","unstructured":"A. Mahdavi et al., The pivotal role of CD69 in autoimmunity, J. Autoimmun., no. March, p. 102453, 2020, doi: 10.1016\/j.jaut.2020.102453.","DOI":"10.1016\/j.jaut.2020.102453"},{"issue":"August","key":"10.1016\/j.cyto.2024.156708_b0170","first-page":"1","article-title":"Decreased expression of CD69 on T cells in tuberculosis infection resisters","volume":"11","author":"Chen","year":"2020","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.cyto.2024.156708_b0175","first-page":"1","article-title":"Study of CD27, CD38, HLA-DR and and Ki-67 Immune Profiles for the Characterization of Active Tuberculosis, Latent Infection and End of Treatment","volume":"July","author":"D\u00edaz-fern\u00e1ndez","year":"2022","journal-title":"Front. Microbiol."},{"issue":"s2","key":"10.1016\/j.cyto.2024.156708_b0180","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13223-018-0278-1","article-title":"An introduction to immunology and immunopathology","volume":"14","author":"Marshall","year":"2018","journal-title":"Allergy Asthma Clin. Immunol."},{"key":"10.1016\/j.cyto.2024.156708_b0185","doi-asserted-by":"crossref","unstructured":"S.H.E. Kaufmann, A. Aiello, S. Naja, D. Goletti, L.H. Gutie, K.L. Hilligan, Initial immune response after exposure to Mycobacterium tuberculosis or to SARS-COV-2\u00a0: similarities and differences, no. August, pp. 1\u201324, 2023, doi: 10.3389\/fimmu.2023.1244556.","DOI":"10.3389\/fimmu.2023.1244556"},{"issue":"5","key":"10.1016\/j.cyto.2024.156708_b0190","doi-asserted-by":"crossref","first-page":"2962","DOI":"10.1128\/IAI.68.5.2962-2970.2000","article-title":"Interleukin-7 or Interleukin-15 Enhances Survival of Mycobacterium tuberculosis -Infected Mice","volume":"68","author":"Maeurer","year":"2000","journal-title":"Infect. Immunity"},{"key":"10.1016\/j.cyto.2024.156708_b0195","doi-asserted-by":"crossref","unstructured":"K.S. Schluns, S. Anthony, Emerging roles for IL-15 in the activation and function of T-cells during immune stimulation, Res. Rep. Biol., p. 25, 2015, doi: 10.2147\/rrb.s57685.","DOI":"10.2147\/RRB.S57685"},{"issue":"1","key":"10.1016\/j.cyto.2024.156708_b0200","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-023-38372-7","article-title":"Identification of immune biomarkers in recent active pulmonary tuberculosis","volume":"13","author":"Shaukat","year":"2023","journal-title":"Sci. Rep."},{"key":"10.1016\/j.cyto.2024.156708_b0205","doi-asserted-by":"crossref","unstructured":"N.A. T\u00e9llez-Navarrete et al., Anti-tuberculosis chemotherapy alters TNFR2 expression on CD4+ lymphocytes in both drug-sensitive and -resistant tuberculosis: however, only drug-resistant tuberculosis maintains a pro-inflammatory profile after a long time, Mol. Med., vol. 27, no. 1, 2021, doi: 10.1186\/s10020-021-00320-4.","DOI":"10.1186\/s10020-021-00320-4"},{"issue":"11","key":"10.1016\/j.cyto.2024.156708_b0210","doi-asserted-by":"crossref","first-page":"4423","DOI":"10.4049\/jimmunol.1600646","article-title":"Transcription factors directing Th2 differentiation: Gata-3 plays a dominant role","volume":"196","author":"O\u2019Garra","year":"2016","journal-title":"J. Immunol."},{"key":"10.1016\/j.cyto.2024.156708_b0215","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/925135","article-title":"CD4 +T cells: differentiation and functions","volume":"2012","author":"Luckheeram","year":"2012","journal-title":"Clin. Dev. Immunol."},{"key":"10.1016\/j.cyto.2024.156708_b0220","doi-asserted-by":"crossref","unstructured":"S. Acharya, A.I. Lumley, L. Zhang, M. Vausort, Y. Devaux, GATA3 as a blood-based RNA biomarker for idiopathic Parkinson\u2019s disease, Int. J. Mol. Sci., vol. 24, no. 12, 2023, doi: 10.3390\/ijms241210040.","DOI":"10.3390\/ijms241210040"},{"issue":"4","key":"10.1016\/j.cyto.2024.156708_b0225","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1615\/CritRevImmunol.v26.i4.30","article-title":"Mycobacterium tuberculosis-specific CD8+ T cells and their role in immunity","volume":"26","author":"Woodworth","year":"2006","journal-title":"Crit. Rev. Immunol."},{"key":"10.1016\/j.cyto.2024.156708_b0230","doi-asserted-by":"crossref","unstructured":"A. Lombardi, S. Villa, V. Castelli, A. Bandera, A. Gori, T-cell exhaustion in mycobacterium tuberculosis and nontuberculous mycobacteria infection: Pathophysiology and therapeutic perspectives, Microorganisms, vol. 9, no. 12, 2021, doi: 10.3390\/microorganisms9122460.","DOI":"10.3390\/microorganisms9122460"}],"container-title":["Cytokine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466624002114?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466624002114?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,8,23]],"date-time":"2024-08-23T23:11:49Z","timestamp":1724454709000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043466624002114"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":46,"alternative-id":["S1043466624002114"],"URL":"https:\/\/doi.org\/10.1016\/j.cyto.2024.156708","relation":{},"ISSN":["1043-4666"],"issn-type":[{"value":"1043-4666","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"T cells exhaustion, inflammatory and cellular activity markers in PBMCs predict treatment outcome in pulmonary tuberculosis patients","name":"articletitle","label":"Article Title"},{"value":"Cytokine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cyto.2024.156708","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"156708"}}